Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hsu

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
The Oncologist|March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomasHope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Nature Communications|April 16, 2015
miR-1269 promotes metastasis and forms a positive feedback loop with TGF-βPengcheng Bu, Lihua Wang, Kai-Yuan Chen, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Investigational New Drugs|November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancerJohn H Strickler, Shannon McCall, Andrew B Nixon, et al.
Annals of Surgery|November 8, 2022
Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific ComplicationsJeremy M Sharib, John M Creasy, Benjamin Wildman-Tobriner, et al.
Cell Metabolism|May 1, 2018
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver MetastasisPengcheng Bu, Kai-Yuan Chen, Kun Xiang, et al.
Annals of Surgical Oncology|January 1, 2025
ASO Visual Abstract: Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding Hai ProgramAnnie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Annals of Surgical Oncology|November 20, 2024
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI ProgramAnnie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCsLizhao Feng, Jianfei Chao, E Tian, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
The Oncologist|March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomasHope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Nature Communications|April 16, 2015
miR-1269 promotes metastasis and forms a positive feedback loop with TGF-βPengcheng Bu, Lihua Wang, Kai-Yuan Chen, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Investigational New Drugs|November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancerJohn H Strickler, Shannon McCall, Andrew B Nixon, et al.
Annals of Surgery|November 8, 2022
Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific ComplicationsJeremy M Sharib, John M Creasy, Benjamin Wildman-Tobriner, et al.
Cell Metabolism|May 1, 2018
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver MetastasisPengcheng Bu, Kai-Yuan Chen, Kun Xiang, et al.
Annals of Surgical Oncology|January 1, 2025
ASO Visual Abstract: Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding Hai ProgramAnnie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Annals of Surgical Oncology|November 20, 2024
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI ProgramAnnie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCsLizhao Feng, Jianfei Chao, E Tian, et al.
Pageof 14